HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
We are proud to share an unequaled level of requirement in our organization, surpassing regulatory standards to deliver excellence.
As a world leader in the healthcare industry, product quality is not just a requirement but an absolute obligation for us.
Our new Quality Policy is rooted in the foundational values of HTL Biotechnology.
It is forward-looking, embodying our leadership’s dedication ๐ญ๐จ ๐๐ง๐ฌ๐ฎ๐ซ๐ข๐ง๐ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐๐ซ ๐ฌ๐๐ญ๐ข๐ฌ๐๐๐๐ญ๐ข๐จ๐ง ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก ๐ข๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐ฏ๐, ๐ฌ๐๐๐, ๐๐ง๐ ๐๐๐๐๐๐ญ๐ข๐ฏ๐ ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ.
๐
The European Society of Cataract and Refractive Surgeons (ESCRS) is a unique opportunity each year to connect with our clients and partners while gaining insights into the key trends shaping the future of ophthalmology.
Weโre pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.